ArticleJournal of pharmacy & bioallied sciences2025
A Prospective Clinical Study to Assess the Efficiency of Subarachnoid Block as Sole Anesthetic Method in Neonates Undergoing Infraumbilical Surgeries.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Spinal anesthesia is increasingly used in neonates to minimize respiratory complications such as apnea and bradycardia. It also avoids delayed recovery associated with general anesthesia (GA) and provides stable intraoperative conditions for infraumbilical surgeries. To assess the efficiency of subarachnoid block (SAB) as a sole anesthetic method in neonates undergoing infraumbilical surgeries and evaluate hemodynamic parameters (PR, BP, SPO Materials and Methods: This prospective observational study was conducted in the Department of Anesthesiology, M.Y. Hospital and MGM Medical College, Indore, with 84 neonates (0-28 days) undergoing infraumbilical surgeries. SAB was administered at the L4-L5 interspinous space using 0.5% hyperbaric bupivacaine (0.5 mg/kg). Results: The mean age was 14.39 days with 62.5% males. Hemodynamic parameters remained stable (HR: 162.5 bpm, SPO Conclusion: SAB is a safe, simple, and cost-effective alternative to GA ensuring hemodynamic stability and minimal postoperative complications in neonates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.